
Abstract 89: Development and characterization of a panel of orthotopic glioblastoma multiforme (GBM) patient-derived xenograft (PDX) mouse models for drug efficacy evaluation
Author(s) -
Carsten H. Nielsen,
Maria Z. Alfsen,
Michael J. Wick,
Melissa M. Rundle,
Johann Mar Gudbergsson,
Mette Munk Jensen,
Lotte K. Kristensen,
Mark U. Juul,
Kyriakos P. Papadopoulos,
Andreas Kjær
Publication year - 2019
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2019-89
Subject(s) - temozolomide , sox2 , medicine , cd44 , cancer research , glioblastoma , tumor microenvironment , magnetic resonance imaging , nestin , pathology , brain tumor , oncology , stem cell , biology , cell , neural stem cell , tumor cells , radiology , genetics , biochemistry , transcription factor , gene